Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 beta-cells is not prevented by catalase

Pancreas. 2007 Jan;34(1):144-51. doi: 10.1097/01.mpa.0000240613.43345.51.

Abstract

Objectives: Although detrimental effects of homocysteine attributed to homocysteine auto-oxidation and generation of hydrogen peroxide (H2O2) have been reported in various cell types, such actions have not been considered in pancreatic beta-cells. This study investigates the acute effects of homocysteine on beta-cell integrity and regulation, in particular, the role of H2O2 generated by auto-oxidation.

Methods: Assessment of beta-cell function was examined during acute 20- or 40-minute incubations with homocysteine using clonal BRIN-BD11 beta-cells.

Results: Homocysteine (50-1000 micromol/L) inhibited basal and glucose-induced insulin secretion in a concentration-dependent manner. Insulinotropic responses to alanine, arginine, 2-ketoisocaproate, elevated Ca, tolbutamide, potassium chloride (KCl), forskolin, and phorbol 12-myristate 13-acetate were also significantly reduced by homocysteine. Likewise, preincubation with homocysteine caused a reduction in the insulinotropic responses to glucose and each of the secretagogues tested. Notably, excess catalase (100 microg/mL) in the buffer, although sufficient to remove homocysteine-derived H2O2, did not alleviate the detrimental effects of homocysteine.

Conclusions: Collectively, these data suggest that homocysteine impairs insulin secretory function by mechanisms independent of H2O2 generation. Although homocysteine may give rise to reactive oxygen species, these observations indicate detrimental non-oxidative pancreatic beta-cell actions of homocysteine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / metabolism
  • Amino Acids / pharmacology
  • Animals
  • Calcium / metabolism
  • Calcium / pharmacology
  • Carcinogens / pharmacology
  • Catalase / pharmacology*
  • Cell Line
  • Clone Cells
  • Colforsin / pharmacology
  • Dose-Response Relationship, Drug
  • Glucose / pharmacology
  • Homocysteine / pharmacology*
  • Hydrogen Peroxide / metabolism
  • Hypoglycemic Agents / pharmacology
  • Insulin / metabolism*
  • Insulin Secretion
  • Insulin-Secreting Cells / cytology
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism*
  • Keto Acids / metabolism
  • Keto Acids / pharmacology
  • Oxidation-Reduction
  • Potassium Chloride / pharmacology
  • Rats
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tolbutamide / pharmacology

Substances

  • Amino Acids
  • Carcinogens
  • Hypoglycemic Agents
  • Insulin
  • Keto Acids
  • Homocysteine
  • Colforsin
  • Potassium Chloride
  • Tolbutamide
  • Hydrogen Peroxide
  • Catalase
  • Glucose
  • Tetradecanoylphorbol Acetate
  • Calcium